✦ LIBER ✦

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

✍ Scribed by Ports, W.C.; Khan, S.; Lan, S.; Lamba, M.; Bolduc, C.; Bissonnette, R.; Papp, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of topical janus kin

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of tofacitinib, an o

✍ K.A. Papp; A. Menter; B. Strober; R.G. Langley; M. Buonanno; R. Wolk; P. Gupta; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Efficacy and safety of topical INCB01842

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Efficacy and safety of combinations of f

✍ Hendriks, A.G.M.; Keijsers, R.R.M.C.; de Jong, E.M.G.J.; Seyger, M.M.B.; van de 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Efficacy and safety results from a phase

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

The effectiveness of tofacitinib, a nove

✍ Paweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, Andrzej Pilc 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 323 KB